It was registered an increase on Inovalon Holdings Inc – Class A (NASDAQ:INOV)’s shares shorted with 3.01%. FINRA issued shares shorted of INOV’s total 12.17 million shares. That’s 3.01% up from 11.81M shares. Previous INOV’s position will need 34 days to restore. It has 353,500 average volume. Inovalon Holdings Inc – Class A float short is 17.92%.

INOV reached $12.33 during the last trading session after $0.01 change.Currently Inovalon Holdings, Inc. is uptrending after 9.75% change in last March 9, 2018. INOV has also 272,494 shares volume. The stock outperformed the S&P 500 by 5.38%.

Inovalon Holdings, Inc., a technology company, provides cloud platforms empowering a data-driven transformation from volume to value models throughout the healthcare industry.The firm is worth $1.88 billion. The firm through, large-scale data interconnectivity capabilities, unparalleled proprietary data sets, advanced analytics, data-driven intervention systems, and industry-leading subject matter expertise, enables the assessment and improvement of clinical and quality outcomes, and financial performance across the healthcare ecosystem.Last it reported negative earnings. It serves health plans and well-known provider organizations, as well as pharmaceutical, medical device, and diagnostics companies.

Inovalon Holdings, Inc. (NASDAQ:INOV) Ratings Coverage

In total 5 analysts cover Inovalon Holdings (NASDAQ:INOV). “Buy” rating has 1, “Sell” are 1, while 3 are “Hold”. 20% are bullish. 7 are the (NASDAQ:INOV)’s analyst reports since November 8, 2018 according to StockzIntelligence Inc. On Thursday, February 21 Robert W. Baird maintained Inovalon Holdings, Inc. (NASDAQ:INOV) with “Hold” rating. On Thursday, February 21 the stock of Inovalon Holdings, Inc. (NASDAQ:INOV) has “Sell” rating given by Piper Jaffray. On Thursday, November 8 the firm earned “Market Perform” rating by Wells Fargo. On Thursday, February 21 the rating was maintained by Morgan Stanley with “Hold”. On Thursday, December 20 Morgan Stanley upgraded the shares of INOV in report to “Equal-Weight” rating.

For more Inovalon Holdings, Inc. (NASDAQ:INOV) news released briefly go to: Seekingalpha.com, Globenewswire.com, Nasdaq.com, Globenewswire.com or Globenewswire.com. The titles are as follows: “A Post Earnings Take On Inovalon – Seeking Alpha” released on August 04, 2018, “Diplomat Selects Inovalon’s Specialty Pharmacy Platform Nasdaq:INOV – GlobeNewswire” on November 28, 2018, “Inovalon Holdings (INOV) Reports Next Week: Wall Street Expects Earnings Growth – Nasdaq” with a publish date: February 13, 2019, “Dr. Isaac Kohane Joins Inovalon Board of Directors – GlobeNewswire” and the last “Molina Healthcare Selects Inovalon to Provide Data-Driven Insights to Improve Member Care – GlobeNewswire” with publication date: December 10, 2018.